22725194
9780756742195
Out of Stock
The item you're looking for is currently unavailable.
Hearing on whether innovator drug companies may be using questionable tactics to delay the entry of generic competitors. Witnesses: Mark A. Barondess; Lester M. Crawford, Acting Commr., & Daniel D. Troy, Chief Counsel, Food & Drug Admin. (FDA); Gregory J. Glover, Ropes & Tray, on behalf of PhRMA; Kathleen D. Jaeger, Pres. & CEO, Generic Pharmaceutical Assoc.; Sharon Levine, Assoc. Exec. Dir., the Permanente Medical Group, on behalf of RxHealthValue; & Timothy J. Muris, Chmn., Fed. Trade Comm. (FTC).Bilirakis, Michael is the author of 'Examining Issues Related to Competition in the Pharmaceutical Market Place: a Review of the FTC Report, Generic Drug Entry Prior to Patent Expiration : Congressional Hearing', published 2004 under ISBN 9780756742195 and ISBN 0756742196.
[read more]